We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

AIDIAN

Aidian, formerly Orion Diagnostica, is a Finnish-based IVD company with almost 50 years of experience in developing a... read more Featured Products: More products

Download Mobile App





Orion Diagnostica Showcases Range of Products in Anaheim

By LabMedica International staff writers
Posted on 05 Aug 2019
Print article
Image: The QuikRead go CRP test is designed as an immunoturbidimetric assay for the in vitro quantitative determination of C-reactive protein (CRP) in K2-EDTA and lithium heparin whole blood, K2-EDTA and lithium heparin plasma, and in serum samples (Photo courtesy of Orion Diagnostica).
Image: The QuikRead go CRP test is designed as an immunoturbidimetric assay for the in vitro quantitative determination of C-reactive protein (CRP) in K2-EDTA and lithium heparin whole blood, K2-EDTA and lithium heparin plasma, and in serum samples (Photo courtesy of Orion Diagnostica).
Orion Diagnostica (Espoo, Finland) showcased its FDA-cleared QuikRead go CRP along with other QuikRead go products at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo held in Anaheim, California, USA, from August 6-8.

Orion Diagnostica specializes in accurate and affordable clinical diagnostic and hygiene monitoring tests. It focuses on point-of-care diagnostic tools that enable healthcare professionals to detect diseases more quickly, make evidence-based diagnoses and treatment decisions, and follow up on treatment outcomes. Orion Diagnostica’s QuikRead go CRP test is an immunoturbidimetric assay for the in vitro quantitative determination of C-reactive protein (CRP) in K2-EDTA and lithium heparin whole blood, K2-EDTA and lithium heparin plasma, and in serum samples.

The test is carried out by means of the company’s QuikRead go instrument, a compact, automatic system that can be connected to HIS/LIS systems. The QuikRead go makes it easy to add patient and/or operator identification information together with the result which is automatically stored in the instrument’s internal memory. Its intuitive user interface enables a variety of settings to be personalized and the instrument can be easily combined with accessories, such as a barcode reader and a printer.

At AACC 2019, Orion Diagnostica also showcased its Hygicult and Easicult products for hygiene monitoring. Orion Diagnostica’s Easicult products are easy to use culture tests intended for monitoring microbial contaminations in industrial fluids. Using Easicult does not require any microbiological expertise, advance preparation or equipment and the slides can easily be used on-site. The test slides can be used as convenient transport media if further analysis of the samples is needed. Similarly, the company’s Hygicult product line comprises of a selection of dipslide culture tests, which are designed for reliable, economic and timesaving on-site microbial detection, especially on surfaces. The slides can also be used as convenient transport media for cultured samples.

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG
New
Ultra-Low Temperature Freezer
iUF118-GX

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.